Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects

Summary

To assess the effect of PEX168 doses on the pharmacokinetics of warfarin in healthy subjects.To provide a scientific basis for clinical drug combination of PEX168. To evaluated the impact of pharmacodynamics coadministrated hypodermic PEX168 and warfarin in healthy subjects. To assess the safety of single doses of warfarin administered with and without PEX168

Timeline

Start

2015-08-01

Primary completion

2015-12-12

Completion

2016-07-13

Drugs

Indications

No indication recorded.